How have the shares performed?
Akoya Biosciences Inc. (AKYA) saw an uptrend of 4.37% in the recent trading with $18.85 being its most recent. The current price level -34.90% lower than the highest price of $28.96 marked by the stock while trading over the past 52-weeks, whereas it is 12.00% higher than the lowest price of $16.83 the company dropped to over past 52-weeks. The latest news story on AKYA appeared in GlobeNewswire under the title “Akoya Biosciences Appoints Diagnostics Industry Leader Scott Mendel to its Board of Directors” on Jun-25-21.
Squeezing the time span to 30 day period shows us the stock is currently trading -14.32% below one month high and is +4.66% above of the lowest during that time.
Akoya Biosciences Inc. Earnings – What Happened With AKYA
Coming around sales and income figures, publically trading companies under normal circumstances post earnings and revenues near to average estimates by the Wall Street analysts, but those could came either above or below estimates and known as surprise factor. During the reported three-month period, company’s sales were $12.21 billion.
AKYA – Akoya Biosciences Inc. Stock Earnings Estimates
Investors get the exact data about the key information of institutional ownership in a listed company through its 13F filings at the Stock Exchange Commission (SEC). The total number of common shares currently owned by the public is 35.55 million. AKYA does have institutional investors; and they hold 45.00% of the stock.
Akoya Biosciences Inc. – Insider Activity and Holdings
As on Apr 29, 2021, Franklin Strategic Series-Franklin Small Cap Growth Fund was the top most holder in Akoya Biosciences Inc. (NASDAQ:AKYA) with an ownership of 0.37 million shares of the company or 1.01% of the stake worth $8.39 million. The filing also reveals American Century Small Cap Growth Fund as the second largest holder in the company with a control over 0.76% of the outstanding shares. Its stake is worth $6.33 million for having 0.28 million shares in hand.
PGIM Jennison Health Sciences Fd also came holding a key position in the company during the recent quarter and it now holds 0.50% of the outstanding shares. With this there are now 12 institutions which have possession in AKYA’s shares.